Status:
COMPLETED
Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY
Lead Sponsor:
XDx
Conditions:
Graft Rejection
Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
The Cardiac Allograft Rejection Gene Expression Observational (CARGO) II Study is designed to provide independent evidence of the clinical performance of the non-invasive AlloMap test. Sensitive detec...
Eligibility Criteria
Inclusion
- New and existing allograft recipients
- All patients (age ≥ 18years) receiving post-transplant care at the enrolling centers
Exclusion
- Concurrent enrollment in a double-blind drug trial (immunosuppressive drugs).
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00761787
Start Date
May 1 2005
End Date
February 1 2009
Last Update
March 9 2009
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
2
Columbia University Medical Center
New York, New York, United States, 10032
3
Texas Heart Institute
Houston, Texas, United States, 77030
4
Medizinische Universität Innsbruck, Klinische Abteilung für Herzchirurgie
Anichstrasse 35, Innsbruck, Austria, A-6020